Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Marion Zerlin"'
Autor:
Marek Samochocki, Alfred Maelicke, Jürgen Ludwig, Ruth Jostock, Andreas Fehrenbacher, Edson X Albuquerque, Marion Zerlin
Publikováno v:
Biological Psychiatry. 49:279-288
Cholinesterase inhibitors are the only approved drug treatment for patients with mild to moderately severe Alzheimer's disease. Interestingly, the clinical potency of these drugs does not correlate well with their activity as cholinesterase inhibitor
Autor:
Alfred Maelicke, Marion Zerlin, Marek Samochocki, Walter Luyten, Edson X. Albuquerque, P. J. Groot Kormelink, Ruth Jostock
Publikováno v:
Acta Neurologica Scandinavica. 102:68-73
Galantamine (ReminyI ) is a novel drug treatment for mild to moderate Alzheimer's disease (AD). Originally established as a reversible inhibitor of the acetylcholine-degrading enzyme acetylcholinesterase (AChE), galantamine also acts as an allosteric
Autor:
Marion Zerlin, Claudia Hinze, Ralf Thiericke, Armin Maier, Corinna Maul, Isabel Sattler, Corinna Koch, Susanne Grabley
Publikováno v:
The Journal of Antibiotics. 52:1124-1134
Based on the chemical screening technique, biomolecular-chemical screening has been developed which makes use of two-dimensional TLC analysis of microbial extracts and combines thin-layer chromatography (RP-18) with binding studies towards DNA. In th
Autor:
Corinna Maul, Alfons Garming, Marion Zerlin, Andreas Kirschning, Mathias Noltemeyer, Ralf Thiericke, Gerald Dräger
Publikováno v:
Chemistry - A European Journal. 4:1324-1333
A set of new hybrid antibiotics can be generated by coupling the naturally occurring ten-membered lactones decarestrictine B and D, which lower cholesterol levels, with deoxygenated glycosyl donors. As demonstrated for bisglycoside 1 these novel glyc
Autor:
Axel Zeeck, Claudia Christner, Ralf Thiericke, Marion Zerlin, Antonietta Taddei, Gerhard Küllertz, Gunter Fischer, Susanne Grabley
Publikováno v:
The Journal of Antibiotics. 51:368-371
Publikováno v:
Natural Product Letters. 10:217-224
Manipulation of the secondary metabolite pattern was studied by feeding various amino acids into cultures of the ‘talented’ Streptomyces sp. (strain FH-S 1623), which already has been found to produce marginolactones (oasomycins A to F, as well a
Autor:
Werner F. Fleck, Heike Hülsmann, Udo Gräfe, Stephan Heinze, Gunter Fischer, Wolfgang Ihn, Gerhard Küllertz, Klausjürgen Dornberger, Michael Ritzau, Marion Zerlin, Claudia Christner, Brigitte Schlegel
Publikováno v:
The Journal of Antibiotics. 50:379-383
Lipohexin was isolated as a novel lipohexapeptide (I) (C39H68N6O9) from three fungal strains, Moeszia lindtneri HKI-0054, Paecilomyces sp. HKI-0055 and Paecilomyces sp. HKI-0096. The structure was elucidated by detailed mass spectrometric and NMR exp
Autor:
Marion Zerlin, Ralf Thiericke
Publikováno v:
Natural Product Letters. 8:163-167
Manipulation of the secondary metabolite pattern was studied by feeding various compounds into growing cultures of the streptazolin (1)-producing organism Streptomyces sp. (strain FH-S 2184). Besides an increase of the yield of (1),caused by a number
Publikováno v:
Nat. Prod. Rep.. 13:365-375
Publikováno v:
ChemInform. 27